- Melt Pharmaceuticals Closes $24 Million Series B Preferred Stock Financing
- Harrow Announces Fourth Quarter and Year-End 2023 Financial Results
- Harrow Will Release Fourth Quarter and Year-End 2023 Financial Results After Market Close on March 19, 2024
- Harrow Licenses Canadian Rights to Apotex for Five Branded Ophthalmic Pharmaceutical Products
- Harrow Announces New Appointments to its Board of Directors
More ▼
Key statistics
As of last trade Harrow Inc (HROWL:NMQ) traded at 24.65, -2.95% below its 52-week high of 25.40, set on Apr 08, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 24.65 |
---|---|
High | 24.66 |
Low | 24.65 |
Bid | 24.65 |
Offer | 24.70 |
Previous close | 24.70 |
Average volume | 3.46k |
---|---|
Shares outstanding | -- |
Free float | -- |
P/E (TTM) | -- |
Market cap | -- |
EPS (TTM) | -- |
Annual div (ADY) | 2.16 USD |
---|---|
Annual div yield (ADY) | 8.73% |
Div ex-date | Apr 12 2024 |
Div pay-date | Apr 30 2024 |
Data delayed at least 15 minutes, as of Apr 23 2024 16:11 BST.
More ▼